Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Cannabis Stock Gainers And Losers From July 14, 2022

GAINERS: MedMen Enterprises (OTC:MMNFF) shares closed up 24.33% at $0.07

GAINERS:

  • MedMen Enterprises (OTC:MMNFF) shares closed up 24.33% at $0.07
  • Tilray (NASDAQ:TLRY) shares closed up 14.60% at $3.69
  • TerrAscend (OTC:TRSSF) shares closed up 13.22% at $2.74
  • Cresco Labs (OTC:CRLBF) shares closed up 12.79% at $3.39
  • Aurora Cannabis (NASDAQ:ACB) shares closed up 12.12% at $1.48
  • Trulieve Cannabis (OTC:TCNNF) shares closed up 9.53% at $12.41
  • Canopy Gwth (NASDAQ:CGC) shares closed up 8.93% at $2.44
  • Village Farms Intl (NASDAQ:VFF) shares closed up 8.19% at $3.04
  • RIV Capital (OTC:CNPOF) shares closed up 7.71% at $0.50
  • Auxly Cannabis Group (OTC:CBWTF) shares closed up 7.52% at $0.06
  • Charlottes Web Holdings (OTC:CWBHF) shares closed up 6.63% at $0.51
  • Sundial Growers (NASDAQ:SNDL) shares closed up 6.12% at $0.33
  • Urban-gro (NASDAQ:UGRO) shares closed up 5.94% at $5.89
  • Curaleaf Holdings (OTC:CURLF) shares closed up 5.63% at $5.26
  • 4Front Ventures (OTC:FFNTF) shares closed up 4.35% at $0.54
  • Cronos Group (NASDAQ:CRON) shares closed up 4.35% at $3.12
  • GrowGeneration (NASDAQ:GRWG) shares closed up 4.05% at $4.37
  • Green Thumb Industries (OTC:GTBIF) shares closed up 3.96% at $9.46
  • Zynerba Pharmaceuticals (NASDAQ:ZYNE) shares closed up 3.70% at $1.12
  • HEXO (NASDAQ:HEXO) shares closed up 3.18% at $0.20

LOSERS:

  • Leviathan Natural Prods (OTC:LVCNF) shares closed down 14.08% at $0.70
  • 22nd Century Group (NASDAQ:XXII) shares closed down 5.24% at $1.81
  • Cansortium (OTC:CNTMF) shares closed down 5.00% at $0.19
  • EnWave (OTC:NWVCF) shares closed down 4.85% at $0.46
  • Nine Energy Service (NYSE:NINE) shares closed down 4.82% at $2.17
  • Cara Therapeutics (NASDAQ:CARA) shares closed down 4.27% at $9.20
  • Item 9 Labs (OTC:INLB) shares closed down 3.20% at $0.67

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts